Unveiling Physiological and Psychosocial Pain Components with an Artificial Intelligence Based Telemonitoring Tool

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorETH Zurich

About this trial

The pAIn-sense study aims to revolutionize the monitoring and treatment of chronic pain, a major health concern that significantly impacts psychological well-being and quality of life. Traditional approaches to pain management face challenges like unspecific drug use and high healthcare costs, and they often leave patients dissatisfied. PAIn-sense aims at comprehensively understanding pain from both physical and emotional perspectives. To accomplish this, the study will employ advanced Artificial Intelligence (AI) techniques and wearable sensing technology. The study aims to monitor patients continuously, during both day and night activities, to gather a multidimensional set of data on their physiological, psychosocial, and pain conditions.

Eligibility criteria

Qualifiers

Ongoing nociceptive pain after an injury or Neuropathic pain (acute or chronic)

Familiar with using electronic devices

Disqualifiers

Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.

Unable or not willing to give informed consent

Trial design

Treatments tested in this trial

  • No intervention

Treatment groups

150 Participants
are divided into 2 treatment groups

Sponsors and collaborators

ETH Zurich

Lead sponsor

Balgrist University Hospital

Collaborator